Erratum to efficacy and safety of mecapegfilgrastim for prophylaxis of chemotherapy-induced neutropenia in patients with breast cancer: a randomized, multicenter, active-controlled phase III trial

Detalles Bibliográficos
Autores principales: Xu, Fengrui, Zhang, Yang, Miao, Zhanhui, Zeng, Xiaohua, Wu, Biao, Cai, Li, Liu, Jinping, Wang, Shusen, Hu, Xichun, Zheng, Wenbo, Chen, Zhiyue, Yang, Qing, Jiang, Zefei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2020
Materias:
Erratum
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7290653/
https://www.ncbi.nlm.nih.gov/pubmed/32566597
http://dx.doi.org/10.21037/atm-2020-23

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7290653/
https://www.ncbi.nlm.nih.gov/pubmed/32566597
http://dx.doi.org/10.21037/atm-2020-23

Ejemplares similares